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1. Introduction 
In pharmaceutical industries, the validation of analytical methods is used to demonstrate 
that the method is fitted for its purpose; it must follow a plan which includes scope, 
performance characteristics, and acceptance limits. Analytical methods need to be validated 
or revalidated prior to their introduction into routine analyses (release of batch). The 
overarching philosophy in current good manufacturing practices (cGMPs) of the twenty - 
first century and robust modern quality systems is the quality that it has to be built into the 
product, and testing alone cannot be relied to ensure the quality of the product. From the 
analytical perspective, it will mean that analytical methods used to test products should 
have quality attributes built into them. In order to apply quality attributes into the analytical 
method, fundamental quality attributes have to be applied by the bench - level scientist. This 
is a paradigm shift that requires the bench - level scientist to have a scientific and technical 
understanding, product knowledge, process knowledge, and/or risk assessment ability to 
appropriately execute the quality functions of analytical method validation. In addition, it 
requires the following procedures: (a) an appropriate training of the bench - level scientist to 
understand the principles involved with method validation, validate an analytical method, 
and understand the principles involved with the method validation, (b) proper 
documentation and understanding and interpreting data, and (c) cross – an understanding 
functional of the effect of their activities on the product and to customers (the patient). 
Management has a responsibility of verifying that gained skills from the training are 
implemented in routine analyses performance. 
This chapter gives a review and strategy for the validation of analytical methods in-house, 
recommendation in documentation and completion of method validation in the 
pharmaceutical environmental. 
2. Regulatory agencies 
In 1990, Europe, United States of America, and Japan harmonized the submission 
requirements for new pharmaceuticals, a forum for constructive dialogues between 
regulatory authorities and industry was initiated and called, “International Conference on 
the Harmonisation” (ICH) (ICH, 2005). One of the first topics into the quality section was 
www.intechopen.com
 
Wide Spectra of Quality Control 
 
4 
analytical validation and the ICH was very helpful in harmonizing terms and definitions as 
well as determining the basic requirements. 
Regulatory authorities in the United States of America (Food and Drug Administration 
(FDA) and the United States Pharmacopeia (USP)) and Brazil (Agência Nacional de 
Vigilância Sanitária (ANVISA)) include guidelines for analytical procedures and methods 
validation. In the United States of America environment, two guidelines by the FDA were 
proposed, one of those for applicants (Food and Drugs Administration, 1987) and another 
one for inspectors and reviewers (Food and Drugs Administration, 1994). The first one is 
also intended to ensure that the analytical procedures have to be applied in an FDA 
laboratory with detailed description of the procedure, for instance, reference materials, as 
well as a discussion of the potential impurities, and others. The second guideline focuses on 
reversed-phase chromatography and provides the whole details regarding critical 
methodological issues as well as indications of acceptability results. The USP has published 
a specific guideline in the chapter 1225. It focuses on the validation of compendia 
procedures by giving definitions and approaches to validate each analytical parameter, in 
addition, it also provides a table which separates the methods into four categories based on 
their use (United States Pharmacopeia, 2011). In Brazil, ANVISA has also proposed an 
industry guidance for analytical methods validation. The RE 899 of 2003 (Brasil, 2003) is an 
approach to validation and it is varied and opened to interpretation. Also it provides a table, 
the same as chapter 1225 of the USP which separates methods into four categories based on 
their use. For example, Category I covers quantitation of active ingredients in dosage forms 
and indicates that accuracy, precision, specificity, linearity, and range are required for 
method validation while limits of detection and quantitation are not necessary. 
The USP 1225 chapter covers only the most common categories of tests which validation 
data should be required. Those categories can be observed on the following lines: 
Category I: Analytical procedures for quantitation of major components in bulk drug
 substances or active ingredients (including preservatives) in finished 
 pharmaceutical products.  
Category II: Analytical procedures for determination of impurities in bulk drug 
 substances or degradation compounds in finished pharmaceutical products. 
 These procedures include quantitative assays and limit tests.  
Category III: Analytical procedures for determination of performance characteristics 
 (e.g., dissolution, drug release, etc.).  
Category IV: Identification tests. 
In Table 1, the required validation characteristics for various types of analytical procedures 
according to USP can be observed. 
The required validation characteristics for each type of analytical procedures according to 
ICH are illustrated in Table 2. The discussion of the validation of analytical procedures is 
directed to the four most common types of analytical procedures: 
• Identification tests. 
• Quantitative tests for impurities' content. 
• Limit tests for the control of impurities. 
• Quantitative tests of the active moiety in samples of drug substance or drug product or 
other selected component(s) in the drug product. 
Even though there are many other analytical procedures, such as dissolution testing for 
drug products or particle size determination for drug substance, these are no addressed in 
the initial text for validation of analytical procedures. The validation of these additional 
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analytical procedures is equally important to those listed herein, and it may be addressed in 
subsequent documents. 
 
Category II Analytical 
performance 
characteristics 
Category I 
Quantitative Limit tests
Category III Category IV 
Accuracy Yes Yes * * No 
Precision Yes Yes No Yes No 
Specificity Yes Yes Yes * Yes 
Detection Limit No No Yes * No 
Quantitation Limit No Yes No * No 
Linearity Yes Yes No * No 
Range Yes Yes * * No 
*It may be required, depending on the nature of the specific test. 
Table 1. Data elements required for validation according to USP 
 
Testing for impurities Type of analytical 
procedure 
Characteristics 
Identification
Quantitative Limit 
Assay 
Accuracy - + - + 
Precision     
Repeatability - + - + 
Interm. precision - + (1) - + (1) 
Specificity (2) + + + + 
Detection Limit - - (3) + - 
Quantitation Limit - + - - 
Linearity - + - + 
Range - + - + 
(-) characteristic is not normally evaluated. (+) characteristic is normally evaluated. 
(1) in some cases where reproducibility (see glossary) has been performed, intermediate precision does 
not need to be done. (2) lack of specificity in one analytical procedure could be compensated by other 
supporting analytical procedure(s). (3) it may be needed in some cases. 
Table 2. Data elements required for validation according to ICH 
 
A brief description of the types of considered tests in this document is provided below. 
• Identification tests are intended to ensure that analyte is into of sample. This is 
normally achieved by comparing the property of the sample (e.g., spectrum, 
chromatographic behavior, chemical reactivity, etc) with a reference standard. 
• Testing for impurities can be either a quantitative test or limit test for the impurity in a 
sample. Both tests are intended to accurately reflect the purity characteristics of the 
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sample. More different validation characteristics are required for a quantitative than for 
a limit test. 
• Assay procedures are intended to measure the presented analyte in a given sample. In 
the context of this document, the assay represents a quantitative measurement of the 
major component(s) in the drug substance. For the drug product, similar validation 
characteristics are also applied when assaying an active or other selected component(s). 
The same validation characteristics may also be applied to associated assays with other 
analytical procedures (e.g., dissolution). 
In Brazil, ANVISA has the same form as ICH and USP, it covers the most common 
categories of tests for analytical method validation: category I, category II, category III, and 
category IV. The Table 3 shows performance characteristics of an analytical method 
validation according to resolution RE 899. 
 
Category II 
Parameter Category I 
Quantitative Limit tests
Category III Category IV 
Specificity Yes Yes Yes * Yes 
Linearity Yes Yes No * No 
Range Yes Yes * * No 
Precision      
Repeatability Yes Yes No Yes No 
Interm. precision ** ** No ** No 
Detection Limit No No Yes * No 
Quantitation Limit No Yes No * No 
Accuracy Yes Yes * * No 
Robustness Yes Yes Yes No No 
* it may be required, depending on the nature of the specific test. 
** If there is evidence of reproducibility is not required intermediate precision. 
Table 3. Data elements required for validation according to RE 899 of ANVISA 
3. Strategy for analytical method validation 
The validation of a specific method must be demonstrated through laboratory experiments 
by routinely analyzing samples. The preparation and execution have to follow a validation 
protocol, preferably written in a step-by-step instruction format. Possible steps for a 
complete method validation are listed in Table 4. This proposed procedure assumes that the 
instrument has been selected, and the method has also been developed. It meets criteria 
such as easy of use, ability to be automated and controlled by computer systems, costs per 
analysis, sample throughput, turnaround time, environmental, health, and safety 
requirements. Successful acceptance of the validation parameters and performance criteria 
by all involved parties requires a cooperative effort of several departments, including 
analytical development, quality control, regulatory affairs, and individuals requiring the 
analytical data. The operating procedure or Validation Master Plan (VMP) must clearly 
define the rules and responsibilities of each involved department in the validation of 
analytical methods.  
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The validation experiments should be carried out by an expert analyst to avoid errors due to 
lack of experience. The analyst should also be very familiar with the technique and 
operation of the instrument. Before an instrument starting validating a method, its 
performance specifications must be verified by using generic chemical standards. Satisfactory 
results for a method can be only obtained with equipment that is performing well. A special 
attention must be paid to equipment characteristics which are critical for the method. For 
instance, if the detection limit is critical for a specific method, the specification of the 
instrument for baseline noise and some detectors must be verified. 
 
1 Develop a validation protocol, an operating procedure, or a validation master plan 
for the validation 
2 For a specific validation project, define owners and responsibilities 
3 Develop a validation project plan 
4 Define the application, purpose, and scope of the method 
5 Define the performance parameters and acceptance criteria 
6 Define validation experiments 
7 Verify relevant performance characteristics of equipment 
8 Qualify materials, e.g. standards and reagents for purity, accurate amounts, and 
sufficient stability 
9 Perform pre-validation experiments 
10 Adjust method parameters and/or acceptance criteria if necessary 
11 Perform full internal (and external) validation experiments 
12 Develop standard operation procedures for executing the method in the routine 
13 Define criteria for revalidation 
14 Define type and frequency of system suitability tests and/or analytical quality 
control checks for the routine 
15 Document validation experiments and results in the validation report 
Table 4. Strategies and steps in analytical method validation 
There are no official guidelines on the correct sequence of validation experiments, and the 
optimal sequence may depend on the method itself. 
Based on the experience of, the following sequence has proven to be very helpful: 
1. Specificity (optimizing separation and detection of standard mixtures if selectivity is 
insufficient). 
2. Linearity, range, limit of detection, and limit of quantitation. 
3. Precision (Repeatability, short-term precision, intermediate precision, and 
reprodutibility). 
4. Accuracy at different concentrations. 
5. Robustness. 
The time-consuming experiments, such as accuracy and ruggedness, are included toward 
the end. Some of the parameters, as listed under (2) to (6), can be measured by combining 
experiments. For example, when the precision of peak areas is measured over the full 
concentration range, the data can be used to validate the linearity. During method 
validation, the parameters, acceptance limits, and frequency of ongoing system suitability 
tests or quality control checks should be defined. Criteria must be defined to indicate when 
the method and system are beyond statistical control. The aim is to optimize these 
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experiments so that, with a minimum number of control analyses, the method and the 
complete analytical system will provide long-term results to meet the objectives defined in 
the scope of the method. 
4. Documentation 
4.1 Validation protocol 
Depending upon of the culture of the company, a method validation protocol could be 
simple (listed below) or exhaustive (in addition to the listed items, each parameter to be 
validated is described in detail): How solutions are going to be made, the experimental 
design, how the calculations are going to be performed, any software to be utilized (e.g., 
Excel). If a full-length protocol is required within a particular company, then the writing of 
this protocol and approval of the protocol would need to be completed prior to the 
commencement of the validation work. Otherwise, there may be many deviations to the 
protocol which will be needed to be referenced in the final method validation report. Some 
companies also have templates for the validation reports, thereby allowing for facile 
population of the results. Once populated, the file is reviewed to determine if all validation 
parameters and acceptance criteria were met. If they were not met, a deviation is added and 
the proper justification must be given. If it is deemed that the justification is not appropriate, 
then an action plan for the specific figure of merit in question is determined (i.e., repeat 
analysis, change of the analytical procedure, and revalidation). Also, if the analytical 
method has not been approved at the time of writing the validation protocol yet, it is 
recommended to attach a final draft of the method to the protocol. 
Before starting the experimental work, the protocols must be written by a qualified person 
and approved by a quality assurance department. Some of the items that are necessary to be 
specified in the validation protocol are listed below: 
• The analytical method for a given product or drug substance. 
• The test to be validated. 
• The test parameters for each test, including type and number of solutions and number 
of tests. 
• The acceptance criteria for each parameter based on an internal standard operational 
procedure (product or method-specific adaptations may be necessary and are acceptable, 
if justified). 
• List of batches of drug substance and/or drug products. 
• For a drug product the grade/quality of the excipients used in the formulation. 
• List of reference materials to be used in the validation experiments. 
• Information of the instruments and apparatus to be used. 
• Responsibilities [author, chemists, analytical research project leader, quality assurance, 
and etc.]. 
4.2 Validation report 
The validation report must contain reference to the analytical methods (specific code 
number used as identifier within the pharmaceutical organization) and the corresponding 
drug substance or product name. Note that for early-phase method validation reports the 
results may be filled in a predefined table and compared with the acceptance criteria. 
However, for late-phase validation, more explicit reports are generated by explaining every 
experiment, with detailed steps of sample and standard preparation. The list of reference 
materials (reference standards with the appropriate certificate of analysis) as well as the list 
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of calibrated and qualified instruments used in the validation experiments should be 
documented in the report. For drug substances the list of the batches of drug substances, 
notebook number/reference number for any individual impurities, or solutions or used 
intermediates should also be listed. For drug products, the list of the batches of drug 
substances, drug product, and the grade/quality of excipients should be listed. The test 
parameters and acceptance criteria must be listed together with the results for each test, and 
the passed or failed results should be indicated. The validation report should also contain 
whether the method validation was successful and if any changes should be applied to the 
analytical method, and then the final analytical method must be resubmitted for quality 
assurance approval. 
Once the method has been developed and validated, a validation report should be prepared 
with the following information: 
• Objective and scope of the method (applicability, type). 
• Summary of methodology. 
• All chemicals, reagents, reference standards, quality control samples with purity, grade, 
their source, or detailed instructions on their preparation. 
• Procedures for quality checks of standards and chemicals used on that. 
• Safety precautions. 
• Method parameters. 
• Critical parameters from robustness testing. 
• Listing of equipment and its functional and performance requirements, e.g., cell 
dimensions, baseline noise, and column temperature range. For complex equipment, a 
picture or schematic diagram may be useful. 
• Detailed conditions on how the experiments were conducted, including sample 
preparation. The report must be detailed enough to ensure that it can be reproduced by 
a competent technician with comparable equipment. 
• Statistical procedures and representative calculations. 
• Procedures for quality control in routine analyses, e.g., system suitability tests. 
• Representative plots, e.g., chromatograms, spectra, and calibration curves. 
• Method acceptance limit performance data. 
• The expected uncertainty of measurement results. 
• Criteria for revalidation. 
• The person(s) who developed and validated the method. 
• References (if any). 
• Summary and conclusions. 
• Approval with names, titles, date, and signature of those responsible for the review and 
approval of the analytical test procedure. 
4.3 Revalidation 
Some method parameters have to be changed or adjusted during the life of the method if the 
method performance criteria fall outside their acceptance criteria. The question is whether 
such change requires revalidation. In order to clarify this question up front, operating 
ranges should be defined for each method, either based on experience with similar methods 
or else investigated during method development. These ranges should be verified during 
method validation in robustness studies and also be part of the method characteristics. 
Availability of such operating ranges makes it easier to decide when a method should be 
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revalidated. A revalidation is necessary whenever a method is changed and the new 
parameter lies outside the operating range. If, for example, the operating range of the 
column temperature has been specified to be between 30°C and 40°C, the method should be 
revalidated if, for whatever reason, the new operating parameter is 41°C. Revalidation is 
also required if the scope of the method has been changed or extended, for instance, if the 
sample matrix changes or operating conditions change. Furthermore, revalidation is 
necessary whether the intention is to use instruments with different characteristics and these 
new characteristics have not been covered by the initial validation. For example, an HPLC 
method may have been developed and validated on a pump with a delay volume of 5mL, 
but the new pump has a delay volume of only 0.5 mL. Part or full revalidation may also be 
considered if system suitability tests, or the results of quality control sample analysis, lie 
outside preset acceptance criteria where the source of the error cannot be traced back to the 
instruments or any other cause. Whenever there is a change that may require part or full 
revalidation, the change should follow a documented change control system. The change 
should be defined, authorized for implementation, and documented. Possible changes may 
include: 
• New samples with new compounds or new matrices. 
• New analysts with different skills. 
• New instruments with different characteristics. 
• New location with different environmental conditions. 
• New chemicals and/or reference standards, and 
• Modification of analytical parameters. 
An evaluation should determine whether the change is within the scope of the method. If so, 
no revalidation is required. If the change lies outside the scope, the parameters for 
revalidation should be defined. After the validation experiments, the system suitability test 
parameters should be investigated and redefined, if necessary. 
5. Parameters for method validation (figures of merit) 
The type and degree of validation depends on the nature of the test. In particular, methods 
described in pharmacopeias may not have to be validated, but those should be verified. 
Different test methods require different validation parameters; as development of the project 
progresses and as analytical and product-specific information is acquired, the analytical 
methods evolve gradually updated. Each company has its own approach and set of 
acceptance criteria for different analytical assays, but these approaches must be within the 
confines of their line unit quality assurance department and be in accordance with any 
regulatory provisions. In this section, a description for each of the parameters to be 
validated (figures of merit) is described in details. 
5.1 Specificity 
An investigation of specificity should be conducted during the validation of identification 
test, the determination of impurities, and the assay. The procedures used to demonstrate 
specificity will depend on the intended objective of the analytical procedure. It is not always 
possible to demonstrate that an analytical procedure is specific for a particular analyte 
(complete discrimination). In this case, a combination of two or more analytical procedures 
is recommended to achieve the necessary level of discrimination (e.g., optically active 
substances, in addition to an achiral HPLC method, a chiral HPLC method may be added). 
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Identity is a general requirement for dosage forms. When determining specificity for 
identity, the assay and related substances or the content uniformity methods can be used. 
Assay and content uniformity methods are quantitated by external reference standard. This 
identity test confirms that the correct active ingredient (s) is presented in correct ratio if 
multiple variants are available. The method could also be used for post-packaging analysis. 
The general requirements are that the sample and standard chromatograms should 
correspond in retention time and normalized peak area within ±10%. The easiest way to 
perform specificity for any HPLC method is to perform this test in conjunction with a forced 
decomposition study. The utilization of mass spectrometry (MS) detector (in series) after a 
Photo Diode Array (PDA) detector to obtain more information is encouraged (in terms of 
mass-to-charge ratio of parent ions, initial fragmentation pattern, and peak purity). 
Specificity is confirmed when an API peak is “pure” (confirmed by PDA and/or MS) and 
there is no interference from placebo solution (placebo dissolved in sample preparation 
solvent) at the retention time of an API peak. 
5.1.1 Forced degradation studies (solid state and solution) 
Forced degradation studies are usually performed during the salt selection process for the 
drug substance. In drug product development, the forced degradation studies of drug 
substance in the presence of excipients are firstly performed during the pre-formulation 
stage to assist in the selection of the most formidable compounds and excipients. This may 
lead to the development of more suitable formulations, packaging, and change in storage 
and manufacturing conditions as the optimal formulation is defined to be used in clinical 
studies. Forced degradation testing is often repeated when the final drug substance route 
and market formulation is defined or the compound enters phase 3 clinical trials. A good 
overview of forced degradation testing according to the regulatory guidance documents, 
with emphasis on what should be considered for late clinical phases and for registration 
application dossiers (i.e., marketing authorization applications or new drug applications), is 
provided by the Impurity Profiling Group (Klick et al., 2005). Forced degradation studies 
(sometimes referred to as stress testing) are also performed in order to demonstrate 
specificity during the development and validation of stability-indicating methods. These 
studies are usually performed at conditions exceeding that of accelerated storage conditions. 
Forced degradation studies may provide information to degradation pathways and 
degradation products that could form during storage of the drug substance or the drug 
product. The main goal of forced degradation studies is to effectively produce samples 
containing representative and realistic degradation products. These degradation products 
should be assessed whether they are (a) related to the drug substance or the excipients or (b) 
due to drug substance–excipient interactions under certain forced degradation conditions. 
A delicate balance of efficiency and severity/duration of stress conditions is needed. 
Overstressing can destroy relevant compounds or generate irrelevant compounds. Under 
stressing may fail to generate important degradation products. The extent of targeted 
degradation should be approximately anywhere from 5% to 10%. The other goal is that the 
potential degradation products that are generated should be resolved from the active 
component during development of a stability-indicating HPLC method. The assessment of 
peak purity using diode array and LC-MS detection are usually employed. These degradation 
products that are generated during the forced degradation studies can be identified, and the 
determination of degradation pathways and mechanisms for the drug substance and drug 
product can be elucidated. Forced degradation studies are carried out either in the solution 
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state and/or in the solid state. Usually the forced degradation testing is carried out on one 
batch of drug substance and/or one formulation blend (capsules and tablets). This forced 
degradation testing should not be part of a formal stability program. 
 
Stress Test Conditions Duration 
Thermal 
(closed container) 
50°C and 80°C 
(ambient RH) 
1 wk and 2wks 
Thermal/oxidative 
(open container) 
50°C and 80°C 
(ambient RH) 
1 wk and 2wks 
Thermal/humidity 
(open container) 
40°C/75% RH 1 wk and 2wks 
Light 
(closed container) 
Ambient 
Maximum 1.2 million lux hours 
and 200 watt hours/square meter 
Light/oxidative 
(open container) 
Ambient 
Maximum 1.2 million lux hours 
and 200 watt hours/square meter 
Table 5. Solid-state forced degradation studies 
 
Test factor Conditions Duration 
pH 
10mg in 2mL water 
10mg in 2 mL of 0.1M HCl 
10mg in 2 mL of 0.1M NaOH 
All in amber volumetric flasks and 
at room temperature 
1 day and 3 days 
Oxidation  
(H2O2) 
10mg/2mL 3% H2O2 
At 5°C and room temperature in 
amber volumetric flasks. If DS is 
not soluble, then pH modification 
may be necessary 
1, 2, and 3 days 
Oxidation  
(metal ion catalyzed) 
10mg/2mL water containing 
100ppm Fe3+, Ni2+, Cu2+  
saturated with bubbled oxygen in 
amber volumetric flasks 
1, 2, and 3 days 
Oxidation  
(saturated with oxygen) 
10mg/2mL saturated with bubbled 
oxygen in amber volumetric flasks 
1, 2, and 3 days 
Light 50mg/10mL wáter ambient 
Maximum 1.2 million  
lux hours and 200 watt 
hours/square meter, 6hr,  
1 day and 2 days 
Heat 10mg in 2 mL water at 50°C 6 hours, 1 day and 2 days 
Table 6. Solution forced degradation studies 
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The temperature/humidity used conditions may be more severe than the typical accelerated 
stability testing conditions in order to generate potential degradation products in a 
reasonable time. The typical forced degradation conditions include thermolytic, hydrolytic, 
oxidative, photolytic (in excess of ICH conditions), high pH (alkaline conditions), and low 
pH (acidic conditions). Outlined in Table 5 and Table 6 are some solid-state and solution 
forced degradation studies, respectively, that could be conducted. 
5.2 Linearity 
The linearity of an analytical procedure is its ability (within a given range) to obtain test 
results which are directly proportional to the concentration (amount) of analyte in the 
sample.  It may be directly demonstrated on the analyte, or on spiked samples using at least 
five concentrations over the whole working range. Moreover a visual evaluation of the 
analyte signal as a function of the concentration, appropriate statistical calculations are 
recommended, such as a linear regression. The parameters slope and intercept, residual sum 
of squares and the coefficient of correlation should be reported. A graphical presentation of 
the data and residuals is recommended. 
The terminology for this validation characteristic is somewhat misleading because linearity 
in the inner sense, i.e., a linear relationship between analyte concentration and test results is 
certainly preferable, but not essential. A better term would have been analytical response. 
Some analytical procedures have intrinsic non-linear response functions, such as 
quantitative TLC, fluorescence detection, etc., but they can of course be validated. The 
primary objective is to validate or verify the calibration model. Consequently, the 
requirements and the relevant parameters depend on the intended mode of calibration. The 
response function of a given analytical procedure is an intrinsic property of the respective 
analyte. That means, with respect to validation, that the answer is of a qualitative kind: Can 
the intended calibration be applied, yes or no? Therefore, solutions of the analyte itself are 
sufficient and there is no need to repeat linearity. Potential influences by the matrix, i.e., the 
linearity of the analytical procedure would be better addressed in accuracy. Often, the 
fundamental response function is known for a given type of analytical procedure, such as a 
linear function for LC with UV detection, according to the Lambert–Beer law. In some cases, 
validation of linearity can be regarded more as a verification of the assumed response 
function, i.e., the absence of (unacceptable) deviations. Primarily, this should be performed 
by means of graphical evaluation of the deviations of the experimental data from the 
assumed response model (residual analysis), known as residual plots. The evaluation of 
numerical parameters is only sensible after verification of the response function, i.e., if only 
random errors exist. 
Frequently, the linearity is evaluated graphically, in addition to or as an alternative to 
mathematical evaluation. The evaluation is made by visually inspecting a plot of signal 
height or peak area as a function of analyte concentration. Because deviations from linearity 
are sometimes difficult to detect, two additional graphical procedures can be used. The first 
is to plot the deviations from the regression line versus the concentration or versus the 
logarithm of the concentration if the concentration range covers several decades. For linear 
ranges, the deviations should be equally distributed between positive and negative values. 
Another approach is to divide signal data by their respective concentrations, yielding the 
relative responses. A graph is plotted with the relative responses on the y-axis and the 
corresponding concentrations on the x-axis, on a log scale. The obtained line should be 
horizontal over the full linear range. At higher concentrations, there will typically be a 
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negative deviation from linearity. Parallel horizontal lines are drawn on the graph 
corresponding, for example, 95 percent and 105 percent of the horizontal line. The method is 
linear up to the point where the plotted relative response line intersects the 95 percent line. 
Figure 1 shows a comparison of the two graphical evaluations on a sample of caffeine using 
HPLC. 
A plot of the data should be included in the report. In addition, an analysis of the deviation 
of the actual data points from the regression line may also be helpful for evaluating 
linearity. In order to establish linearity, a minimum of five concentrations is recommended. 
Other approaches should be justified. Plotting the sensitivity (response/amount) gives clear 
indication of the linear range. Plotting the amount on a logarithmic scale has a significant 
advantage for wide linear ranges. 
 
 
Fig. 1. Linearity plot of an analyte sample 
5.2.1 Range 
The range of an analytical method is the interval between the upper and lower levels 
(including these levels) that have been demonstrated to be determined with precision, 
accuracy, and linearity using the method as written. The range is normally expressed in the 
same units as the test results. For assay test, it requires a minimum of specified range to be 
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80 to 120 percent of the test concentration, and for the determination of an impurity, the 
range to extend from the limit of quantitation, or from 50 percent of the specification of each 
impurity, whichever is greater to 120 percent of the specification. 
5.2.2 Limit of detection 
The limit of detection is the point at which a measured value is larger than the uncertainty 
associated with it. It is the lowest concentration of analyte in a sample that can be detected, 
but not necessarily quantified. The limit of detection is frequently confused with the sensitivity 
of the method. The sensitivity of an analytical method is the capability of the method to 
discriminate small differences in concentration or mass of the test analyte. In practical terms, 
sensitivity is the slope of the calibration curve that is obtained by plotting the response against 
the analyte concentration or mass. In chromatography, the detection limit is the injected 
amount that results in a peak with a height at least two or three times as high as the baseline 
noise level. Furthermore this signal/noise method describes three more methods (ICH): 
• Visual inspection: The detection limit is determined by the analysis of samples with 
known concentrations of analyte and by establishing the minimum level at which the 
analyte can be reliably detected. 
• Standard deviation of the response based on the standard deviation of the blank: Measurement 
of the magnitude of analytical background response is performed by analyzing an 
appropriate number of blank samples and calculating the standard deviation of these 
responses. 
• Standard deviation of the response based on the slope of the calibration curve: A specific 
calibration curve is studied using samples containing an analyte in the range of the limit 
of detection. The residual standard deviation of a regression line, or the standard 
deviation of y-intercepts of regression lines, may be used as the standard deviation. 
5.2.3 Limit of quantitation 
The limit of quantitation is the minimum injected amount that produces quantitative 
measurements in the target matrix with acceptable precision in chromatography, typically 
requiring peak heights 10 to 20 times higher than the baseline noise. If the required precision 
of the method at the limit of quantitation has been specified, the EURACHEM approach can 
be used. A number of samples with decreasing amounts of the analyte are injected six times. 
The calculated RSD percent of the precision is plotted against the analyte amount. 
The amount that corresponds to the previously defined required precision is equal to the 
limit of quantitation. It is important to use not only pure standards for this test but also 
spiked matrices that closely represent the unknown samples. For the limit of quantitation, 
the ICH recommends, in addition to the procedures as described above, the visual 
inspection and the standard deviation of the response and the slope of the calibration curve. 
Any results of limits of detection and quantitation measurements must be verified by 
experimental tests with samples containing the analytes at levels across the two regions. It is 
equally important to assess other method validation parameters, such as precision, 
reproducibility and accuracy, close to the limits of detection and quantitation. Figure 2 
illustrates both the limit of detection and the limit of quantitation. 
5.3 Precision 
Precision provides an indication of random errors and can be broken down into 
repeatability and intermediate precision. This procedure should only be performed when 
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Limit of detection Limit of quantitation
Signal/Noise = 2-3 Signal/Noise = 10-20 Signal
Noise
 
Fig. 2. Limit of detection and limit of quantitation via signal to noise 
the entire analytical method procedure is finalized. Repeatability represents the simplest 
situation and involves analysis of replicates by the same analyst, generally one injection 
after the other. Repeatability tests are mandatory for all tests delivering numerical data. 
Repeatability is divided into two parts: injection repeatability and analysis repeatability 
(multiple preparations). Validation of the precision of an HPLC method occurs at three 
stages. The first stage is injection precision (injection repeatability) based on multiple 
injections of a single preparation of a sample on a particular sample on a given day. The set 
of criteria is given for area (% area normalization) methods (drug substance and drug 
product) based on %RSD of peak area. The second stage is analysis repeatability where 
multiple preparations and multiple injections of a sample are analyzed by the same chemist 
on the same day. The third stage is intermediate precision and is usually performed by 
different analysts, on a different system, on a different day on the same drug substance or 
drug product batch to determine the variability of the analytical test. The intermediate 
precision test may give indications to potential issues that may arise during method transfer. 
Relative standard deviation or coefficient of variation (Srel or %RSD) is used to assess 
whether the adequate precision has been obtained. If automation is utilized, then an 
intermediate precision test is required to compare results obtained through manual testing 
versus automated testing (if all solvent composition and analyte concentrations of all actives 
are identical in both methods). 
5.3.1 Repeatability 
In addition to the system precision, this short-term variability includes the contributions 
from the sample preparation, such as weighing, aliquoting, dilution, extraction, 
homogenisation, and etc. Therefore, it is essential to apply the whole analytical procedure 
(as described in the control test), rather merely to injecting the same sample solution six 
times. This is also the reason for using authentic samples because only then can the 
analytical procedure be performed exactly as in the routine application. There may be 
exceptions, but these should be demonstrated or cautiously justified. For example, analysing 
degradants near of the quantitation limit, where the variance contribution of the sample 
preparation can be neglected, injection precision and repeatability are identical. For some 
applications, where precision can be regarded as less critical, such as in early development 
or if the variability demands only a small part of specification range (less than 
approximately 10 %), or if the expected content of impurities is far away from the 
specification limit, artificially prepared (spiked) samples may be used, allowing several 
validation characteristics (linearity, precision and accuracy) to be addressed simultaneously. 
Repeatability can be calculated using Eq.(1) and Eq. (2) from a larger number of repeatedly 
prepared samples (at least 6). 
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Where s is the standard deviation, xi is the individual measurement in a set of n measurements 
and x  is the mean of all the measurements. %RSD is the standard deviation in percentage. 
5.3.2 Intermediate precision 
Intermediate precision includes the influence of additional random effects according to the 
intended use of the procedure in the same laboratory and can be regarded as an (initial) 
estimate for the long-term variability. Relevant factors, such as operator, instrument, and 
days should be varied. Intermediate precision is obtained from several independent series of 
applications of the (whole) analytical procedure to (preferably) authentic, identical samples. 
In some cases of relative techniques, the preparation and analysis of the reference standard 
is an important variability contribution. Therefore, it is not appropriate to determine 
intermediate precision from the peak area of the sample alone (analysed on different days or 
even several concentrations only), as it is sometimes reported in validation literature. Apart 
from ignoring the contribution of the reference standard, any signal shift of the instrument 
will be falsely interpreted as random variability. In order to reflect the expected routine 
variability properly, the calibration must be performed exactly as described in the control 
test. Reproducibility, according to the ICH definition, is obtained by varying further factors 
between laboratories and is also particularly important in the assessment of “official” 
compendia methods or whether the method is applied at different sites. However, 
understood in the long-term perspective, both intermediate precision and reproducibility 
approach each other, at least in the same company. Reproducibility from collaborative trials 
can be expected to include additional contributions due to a probably larger difference of 
knowledge, experience, equipment, and etc. among the participating laboratories. 
5.3.3 Reprodutibility 
Reproducibility represents the precision obtained between different laboratories. The 
objective is to verify that the method will provide the same results in different laboratories. 
The reproducibility of an analytical method is determined by analyzing aliquots from 
homogeneous lots in different laboratories with different analysts, and by using operational 
and environmental conditions that may differ from, but they are still within, the specified 
parameters of the method (interlaboratory tests). Validation of reproducibility is important 
whether the method is to be used in different laboratories. The main factors affecting the 
reprodutibility are: 
• Differences in room temperature and humidity. 
• Operators with different experience and thoroughness. 
• Equipment with different characteristics, e.g., delay volume of an HPLC system. 
• Variations in material and instrument conditions, e.g., HPLC, composition of mobile 
phase, pH, and flow rate of mobile phase. 
• Variation in experimental details not specified by the method. 
• Equipment and consumables of different ages. 
• Columns from different suppliers or different batches. 
• Solvents, reagents, and other materials with varying quality. 
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5.4 Accuracy 
The accuracy of an analytical method is the extent to which test results generated by the 
method and the true value agree. Accuracy can also be described as the closeness of 
agreement between the value that is adopted, either as a conventional, true, or accepted 
reference value, and the value found. For the quantitative approaches, at least nine 
determinations across the specified range should be obtained, for example, three replicates 
at three concentration levels each. The percentage recovery or the difference between the 
mean and the accepted true value together with the confidence intervals are recommended. 
The expected recovery (Table 7) depends on the sample matrix, the sample processing 
procedure, and the analyte concentration. The AOAC Guidelines for Single Laboratory 
Validation of Chemical Methods for Dietary Supplements and Botanicals (AOAC, 2002) 
includes a table with estimated recovery data as a function analyte concentration. 
 
Active Ingredient (%) Analyte ratio Unit Mean recovery (%) 
100 1 100% 98 – 102 
≥ 10 10 -1 10% 98 – 102 
≥ 1 10 -2 1% 97 – 103 
≥ 0.1 10 -3 0.1% 95 – 105 
≥ 0.01 10 -4 100 ppm 90 – 107 
≥ 0.001 10 -5 10 ppm 80 – 110 
≥ 0.0001 10 -6 1 ppm 80 – 110 
≥ 0.00001 10 -7 100 ppb 80 – 110 
≥ 0.000001 10 -8 10 ppb 60 – 115 
≥ 0.0000001 10 -9 1 ppb 40 – 120 
Table 7. Analyte recovery at different concentrations 
In drug substance, it can be rather difficult to demonstrate accuracy for a drug substance 
appropriately, especially if no (independently) characterised reference standard is available. 
In addition, independent analytical procedures are often not readily found. Nevertheless, 
every effort should be made to identify a suitable method for comparison because this is the 
only way to verify accuracy objectively. Instead of quantitative comparison, the results 
could also be supported by another method, for example, the verification of a very high 
purity of a drug substance by differential scanning calorimetry. Sometimes in validation 
literature, recovery is reported for a drug substance. However, recovery from simple 
solutions does not provide meaningful information (at least if all determinations are traced 
back to a reference standard characterized with the same analytical procedure) and it, 
therefore, is not appropriate to demonstrate accuracy. 
In drug product, the accuracy is usually validated by analysing a synthetic mixture of the 
drug product components which contain known amounts of a drug substance, also termed 
spiking or reconstituted drug product. The experimentally obtained amount of active 
substance is then compared to the true, added amount (recovery). It can be calculated either 
at each level separately as a percentage recovery or as a linear regression of the found 
analyte versus the added one (recovery function). Sometimes the term “recovery” is 
misused when reporting in active content of the drug product batches. This is misleading 
because in some cases, the true amount of active is influenced by manufacturing the 
variability and is not exactly known. Preferably, the result should be termed “% label 
claim”. The analyst should be aware of two important aspects regarding respect to recovery. 
First of all, it is based on the (validated) accuracy of the drug procedure substance otherwise 
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the added amount will already be wrong. Secondly, by preparing the reconstituted drug 
product, the analyst deviates (more or less) from the routine analytical procedure. Of course, 
there is no other possibility of adding exactly known amounts, but consideration should be 
given to the possible implications. If, for example, solutions of the placebo are spiked with a 
stock solution of the active substance, the influence of the missed sample preparation steps, 
such as grinding, extracting, and etc. on the analysis should be considered. Here, the 
information obtained during the development of the method is very helpful (for example, 
homogeneity or extraction investigations). If some steps are of importance, any problems 
related to them will not influence the experimental recovery, and therefore, they are not 
identified. 
5.5 Robustness 
Robustness tests examine the effect that operational parameters have on the analysis results. 
For the determination of robustness, a number of method parameters are varied within a 
realistic range, and the quantitative influence of the variables is determined. If the influence 
of the parameter is within a previously specified tolerance, the parameter is said to be 
within the robustness of the method range. Obtaining data on these effects helps to assess 
whether a method needs to be revalidated, for instance, when one or more parameters are 
changed to compensate the column performance over time. In the ICH document, it is 
recommended to consider the evaluation of robustness of the method during the 
development phase, and any results that are critical for the method should be documented.  
In summary, an analyst must have a critical look at three different types of parameters when 
robustness and ruggedness are investigated: 
• Internal parameters (e.g., temperature, pH, and etc., in the case of HPLC). 
• External parameters (e.g., different analysts, instruments, laboratories, and etc.). 
• Basic parameters (e.g., stability of test solutions and etc.). 
From these lists, one point becomes very clear. A test for robustness is an individual test and 
depends very much on the analytical technique and equipment applied. As a rule of thumb, 
it is recommended to examine at least those parameters which are part of the operational 
qualification of the respective equipment. Then, the set of parameters investigated in a 
robustness study can be arbitrarily extended to those specific to the method defined in the 
procedure. The usual way to performing robustness testing is first to define the parameters 
with reasonable maximum variation. Then, each parameter is successively varied whereas 
the others are held constant (at nominal setting). For instance, six parameters each one at 
two levels would require twelve experiments when one parameter is changed and the others 
are always set to nominal levels. If more parameters are included, more experiments must 
be conducted. This classical approach is called one-factor-a-time (OFAT) approach. 
Certainly, this kind of robustness testing has disadvantages, such as many experiments and 
time. In addition, only limited information is made available from such studies, since 
possible interactive effects which occur when more than one parameter (factor) is varied, 
cannot be identified. Nowadays, an experimental design approach (DOE: design of 
experiment) is often preferred for robustness testing. The aim of an experimental design is to 
obtain as much as possible relevant information in the shortest time from a limited number 
of experiments. Different designs can be used in robustness testing, e.g. including full– and 
fractional – factorial designs as well as Plackett–Burman designs. The latter have become 
very popular in method robustness testing during recent years. The choice of a design 
depends on the purpose of the test and the number of involved factors. Experimental 
designs in robustness testing can be employed for all analytical techniques. 
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6. Conclusion 
This chapter described the fundamentals and figures of merit for method validation in 
pharmaceutical analysis. The validation process is to confirm that the method is suited for 
its intended purpose and to prove the capabilities of the test method. The definitions of 
method validation parameters are well explained by health authorities. Although the 
requirements of validation have been clearly documented by regulatory authorities, the 
approach to validation is varied and opened to interpretation, and validation requirements 
differ during the development process of pharmaceuticals. 
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